Tag Archives: asthma

May, 2017

3 May
AstraZeneca and Pieris Enter up to $2.1 Billion Deal in Respiratory Drug Collaboration

AstraZeneca today announced a strategic collaboration in respiratory diseases with Pieris Pharmaceuticals, Inc. to develop novel inhaled drugs that leverage Pieris’ Anticalin® platform. Anticalin molecules are engineered proteins which can mimic antibodies by binding to sites either on other proteins or on small molecules. They are smaller than monoclonal antibodies, offering …
Share

24 March
Teva’s Cinqair Granted FDA Approval for Treatment of Severe Asthma

JERUSALEM–(BUSINESS WIRE)–Mar. 23, 2016– Teva Pharmaceutical Industries Ltd.(NYSE and TASE: TEVA) today announced that the U.S. Food and Drug Administration(FDA) has approved CINQAIR® (reslizumab) Injection, an interleukin 5 antagonist monoclonal antibody (IgG4 kappa) indicated for add-on maintenance treatment of patients with severe asthma aged 18 years and older, and with …
Share
7 March
AbbVie Pays $595 Million for Rights to Boehringer Ingelheim’s Psoriasis Drug

NORTH CHICAGO, Ill. & INGELHEIM, Germany–(BUSINESS WIRE)–AbbVie (NYSE:ABBV) and Boehringer Ingelheim today announced a global collaboration to develop and commercialize BI 655066, an anti-IL-23 monoclonal biologic antibody in Phase 3 development for psoriasis. AbbVie and Boehringer Ingelheim also are evaluating the potential of this biologic therapy in Crohn’s disease, psoriatic …
Share